Products expand interventional cardiology offering

Posted By : Enaie Azambuja
Products expand interventional cardiology offering


Cordis, Cardinal Health’s interventional vascular business, has announced the commercial launch of three new products that further enhance its interventional cardiology product portfolio in Europe, the Middle East, and Africa (EMEA).

The addition of the Cordis RAILWAY Sheathless Access System as well as Ikazuchi Zero and Raiden3, Kaneka’s percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, further strengthen Cordis’ product offering that supports the treatment of patients undergoing percutaneous coronary intervention (PCI) from access and diagnostic to intervention and closure. 

Cordis and Cardinal Health will showcase their newly expanded competitive and value-based product and services offering at EUROPCR 2017 from May 16-19 in Paris, France (booth F26). 

“Strong results from Cordis innovation programs and new distribution agreements have rapidly strengthened our product offering in interventional cardiology in EMEA,” said Bertrand Deluard, President, Cardinal Health, EMEA.

“These cardiology products nicely complement the drug-eluting stents we launched in EMEA last year and we remain committed to making significant contributions to the healthcare system by delivering value-based products and solutions to our customers and their patients.”

 “With the complexity of healthcare today, our customers and their patients require partners who can help them gain access to high quality products and solutions at a reasonable cost,” said David Wilson, President, Cordis.

”With our extensive and growing product offering and business solutions, Cordis, as a Cardinal Health company, remains uniquely positioned to deliver on this promise in EMEA and around the world.” 

New Products Featured at EUROPCR 2017

  • Cordis received the CE Mark for its new RAILWAY Sheathless Access System, which is now available in select countries across Europe. The RAILWAY Sheathless Access System is indicated for use in radial arterial procedures requiring percutaneous introduction of intravascular devices. This Cordis device enables direct access to the radial artery with either ADROIT
  • Cordis is now launching the Ikazuchi Zero and Raiden 3 PTCA balloons under the Kaneka brand name across EMEA. In October 2016 Cardinal Health signed a distribution agreement with Japanese manufacturer Kaneka that enables Cordis to distribute Kaneka’s PTCA balloon catheters, which recently received CE Mark in EMEA. These Japanese PTCA balloons are engineered for smaller and narrower lesions, suiting them for both everyday and complex cases. Ikazuchi Zero includes the lowest-profile 1.0mm diameter pre-dilatation balloon available, and RAIDEN3 offers powerful Rated Burst Pressures of up to 22 atm, amongst the highest on the market.


You must be logged in to comment

Write a comment

No comments

More from Cardinal Health

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Med-Tech Innovation Expo 2018
25th April 2018
United Kingdom Ricoh Arena, Coventry